(Q57664843)

English

Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer

No description defined

Statements

Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
Stephan Wolf
0 references
Armin Pscherer
0 references
Petra Schroeter
0 references
Dirk Winkler
0 references
Hermann-Josef Gröne
0 references
1 April 2006
0 references
118
0 references
1831-1835
0 references
7
0 references

Identifiers

0 references
0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit